Rosetta Genomics Ltd. buy melinda
Start price
07.04.17
/
50%
€2.40
Target price
17.05.17
€3.61
Performance (%)
-40.39%
End price
17.05.17
€1.43
Summary
This prediction ended on 17.05.17 with a price of €1.43. The BUY prediction by melinda for Rosetta Genomics Ltd. performed very badly with a performance of -40.39%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Rosetta Genomics Ltd. | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
Comments by melinda for this prediction
In the thread Rosetta Genomics Ltd. diskutieren
Gesundheit | Medical Laboratories & Forschung | Israel
hat $
(Vom Mitglied beendet)
Stopped prediction by melinda for Rosetta Genomics Ltd.
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€0.97
03.10.17
03.10.17
€1.35
27.12.17
27.12.17
-48.91%
27.12.17
27.12.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.08
03.10.17
03.10.17
€1.50
27.12.17
27.12.17
-48.91%
27.12.17
27.12.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.33
17.05.17
17.05.17
€1.80
25.05.17
25.05.17
38.52%
25.05.17
25.05.17